Indegene Recognized as Front-Runner in GenAI Life Sciences Market Adoption by Everest Group
Bengaluru: Indegene, a leading healthcare technology company, has been recognized as a front-runner in generative AI (GenAI) life sciences market adoption by Everest Group, a global research and consulting firm.
Everest Group’s report, ‘AI-deas to Action: Operationalizing Generative AI in Life Sciences’, acknowledged Indegene’s comprehensive GenAI capabilities, including scale, breadth of use cases, strategic partnerships, and value delivered to clients.
The report highlights Indegene’s holistic GenAI strategy and enterprise-grade solutions, which are helping life sciences companies streamline operations and achieve productivity improvements across clinical, medical, and commercial use cases.
Tarun Mathur, CTO, Indegene, stated, “We believe GenAI is a generational opportunity for life sciences leaders to drive transformational business impact. This recognition by Everest Group reinforces our commitment to contextualizing GenAI for challenging use cases and delivering fit-for-purpose solutions.”
Everest Group assessed service providers’ GenAI capabilities based on scale, industry-specific use cases, strategic partnerships, and measurable value realized by clients.
